| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.743 | 0.005 | 0.743 | Caspase 3 stimulant | 0.499 0.02 CID_154699978 | ||
| 0.592 | 0.051 | 0.592 | Apoptosis agonist | 0.469 0.084 CID_154699978 | ||
| 0.444 | 0.004 | 0.444 | Sigma 1 receptor antagonist | |||
| 0.442 | 0.003 | 0.442 | Ferrochelatase inhibitor | |||
| 0.431 | 0.015 | 0.431 | Calcium channel activator | |||
| 0.414 | 0.005 | 0.414 | UDP-glucose 4-epimerase inhibitor | |||
| 0.393 | 0.003 | 0.393 | Melatonin 2 agonist | 0.034 0.022 CID_154699978 | ||
| 0.416 | 0.025 | 0.416 | DNA damaging | |||
| 0.371 | 0.012 | 0.371 | Tyrosine 3 hydroxylase inhibitor | 0.196 0.142 CID_154699978 | ||
| 0.362 | 0.009 | 0.362 | Amyloid beta precursor protein antagonist | |||
| 0.353 | 0.005 | 0.353 | Aminoacyl-tRNA synthetase inhibitor | 0.164 0.015 CID_154699978 | ||
| 0.359 | 0.031 | 0.359 | Transcription factor STAT inhibitor | 0.283 0.066 CID_154699978 | ||
| 0.381 | 0.07 | 0.381 | GABA C receptor rho-3 antagonist | |||
| 0.319 | 0.014 | 0.319 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.306 | 0.001 | 0.306 | Kallikrein 7 inhibitor | 0.09 0.007 CID_154699978 | ||
| 0.302 | 0.005 | 0.302 | Sigma receptor antagonist | |||
| 0.397 | 0.104 | 0.397 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.329 | 0.054 | 0.418 | Sodium/bile acid cotransporter inhibitor | 0.418 0.013 CID_154699978 | CID_154699978 | |
| 0.306 | 0.04 | 0.306 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.294 | 0.046 | 0.294 | DNA synthesis inhibitor | |||
| 0.259 | 0.014 | 0.259 | MAP kinase kinase inhibitor | |||
| 0.263 | 0.022 | 0.263 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.246 | 0.009 | 0.661 | Histidine decarboxylase inhibitor | 0.661 0.001 CID_154699978 | CID_154699978 | |
| 0.244 | 0.008 | 0.244 | MAP kinase kinase 5 inhibitor | |||
| 0.221 | 0.009 | 0.221 | Triose-phosphate isomerase inhibitor | |||
| 0.212 | 0.006 | 0.212 | CYP2A6 inhibitor | |||
| 0.217 | 0.013 | 0.217 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.211 0.014 CID_154699978 | ||
| 0.222 | 0.02 | 0.222 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.199 | 0.003 | 0.199 | NMDA 2D receptor antagonist | |||
| 0.205 | 0.01 | 0.205 | Glutamate dehydrogenase inhibitor | 0.172 0.013 CID_154699978 | ||
| 0.217 | 0.026 | 0.217 | ATPase inhibitor | |||
| 0.195 | 0.005 | 0.195 | Purinergic P2X2 antagonist | |||
| 0.313 | 0.125 | 0.313 | Antibacterial | 0.26 0.168 CID_154699978 | ||
| 0.19 | 0.002 | 0.19 | DNA polymerase III inhibitor | |||
| 0.256 | 0.075 | 0.256 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.203 | 0.027 | 0.203 | Aldehyde dehydrogenase inhibitor | |||
| 0.235 | 0.061 | 0.235 | MAP kinase kinase 2 inhibitor | |||
| 0.211 | 0.038 | 0.211 | MAO inhibitor | |||
| 0.249 | 0.083 | 0.249 | Aldehyde oxidase inhibitor | |||
| 0.171 | 0.005 | 0.171 | GABA aminotransferase inhibitor | |||
| 0.192 | 0.026 | 0.192 | Cystathionine beta-synthase inhibitor | |||
| 0.188 | 0.026 | 0.188 | Cathepsin H inhibitor | |||
| 0.245 | 0.087 | 0.286 | Transcription factor STAT3 inhibitor | 0.286 0.06 CID_154699978 | CID_154699978 | |
| 0.204 | 0.046 | 0.204 | Succinate dehydrogenase inhibitor | |||
| 0.187 | 0.03 | 0.226 | Alkylator | 0.226 0.02 CID_154699978 | CID_154699978 | |
| 0.166 | 0.014 | 0.166 | DOPA decarboxylase inhibitor | |||
| 0.211 | 0.062 | 0.211 | Non-steroidal antiinflammatory agent | |||
| 0.147 | 0.006 | 0.147 | NMDA receptor subunit 3B antagonist | |||
| 0.2 | 0.063 | 0.2 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.164 | 0.029 | 0.164 | GABA C receptor agonist | |||
| 0.144 | 0.009 | 0.144 | ATPase (Vacuolar H+) inhibitor | |||
| 0.168 | 0.036 | 0.168 | MAO A inhibitor | |||
| 0.206 | 0.077 | 0.206 | Psychostimulant | |||
| 0.136 | 0.008 | 0.136 | D-Ala-D-Ala ligase inhibitor | |||
| 0.145 | 0.018 | 0.145 | Chymotrypsin inhibitor | 0.116 0.027 CID_154699978 | ||
| 0.143 | 0.022 | 0.143 | Electrolyte absorption antagonist | |||
| 0.149 | 0.031 | 0.149 | Photosensitizer | |||
| 0.153 | 0.035 | 0.153 | Ca2+-transporting ATPase inhibitor | |||
| 0.121 | 0.004 | 0.121 | Glutamate (mGluR7) antagonist | |||
| 0.138 | 0.023 | 0.138 | Porphobilinogen synthase inhibitor | |||
| 0.121 | 0.007 | 0.121 | NMDA receptor subunit 3A antagonist | |||
| 0.127 | 0.014 | 0.127 | MAP kinase kinase 10 inhibitor | |||
| 0.117 | 0.004 | 0.117 | AMPA 4 receptor antagonist | 0.079 0.006 CID_154699978 | ||
| 0.113 | 0.004 | 0.113 | Melatonin 1 agonist | |||
| 0.199 | 0.091 | 0.199 | Nitric-oxide synthase stimulant | |||
| 0.137 | 0.032 | 0.145 | Adenylate kinase inhibitor | 0.145 0.028 CID_154699978 | CID_154699978 | |
| 0.166 | 0.061 | 0.166 | Hexokinase inhibitor | |||
| 0.114 | 0.009 | 0.114 | Dopamine transporter inhibitor | |||
| 0.129 | 0.024 | 0.129 | Estrogen receptor beta antagonist | |||
| 0.139 | 0.035 | 0.139 | Carbonic anhydrase XV inhibitor | |||
| 0.138 | 0.034 | 0.138 | Transcription factor STAT6 inhibitor | |||
| 0.123 | 0.02 | 0.123 | Keratolytic | |||
| 0.117 | 0.018 | 0.117 | CDK2/cyclin E inhibitor | |||
| 0.099 | 0.001 | 0.099 | Complement factor 1r inhibitor | |||
| 0.128 | 0.03 | 0.128 | Androgen antagonist | |||
| 0.126 | 0.03 | 0.126 | MAP kinase kinase 1 inhibitor | |||
| 0.233 | 0.137 | 0.233 | Cholesterol antagonist | |||
| 0.102 | 0.006 | 0.102 | Thymidine kinase inhibitor | |||
| 0.151 | 0.058 | 0.151 | MAP3K9 inhibitor | |||
| 0.125 | 0.032 | 0.125 | Alcohol dehydrogenase inhibitor | 0.094 0.059 CID_154699978 | ||
| 0.205 | 0.112 | 0.217 | Superoxide dismutase inhibitor | 0.217 0.1 CID_154699978 | CID_154699978 | |
| 0.094 | 0.002 | 0.094 | Complement factor 1 inhibitor | |||
| 0.102 | 0.011 | 0.102 | Prostaglandin F2 alpha antagonist | |||
| 0.127 | 0.036 | 0.127 | Creatine kinase inhibitor | |||
| 0.133 | 0.043 | 0.133 | Caspase 3 inhibitor | 0.13 0.047 CID_154699978 | ||
| 0.129 | 0.039 | 0.129 | Estrogen antagonist | |||
| 0.12 | 0.03 | 0.12 | Histamine N-methyltransferase inhibitor | |||
| 0.098 | 0.009 | 0.098 | Estrogen receptor alpha agonist | |||
| 0.1 | 0.013 | 0.1 | Acetyl-CoA transferase inhibitor | |||
| 0.11 | 0.024 | 0.11 | Glycine receptor antagonist | |||
| 0.096 | 0.011 | 0.096 | Elastase inhibitor | 0.06 0.03 CID_154699978 | ||
| 0.087 | 0.006 | 0.087 | Potassium channel (Inward rectifier) activator | |||
| 0.201 | 0.121 | 0.201 | 5 Hydroxytryptamine release stimulant | |||
| 0.091 | 0.011 | 0.091 | MDM2 inhibitor | |||
| 0.097 | 0.017 | 0.097 | Glutamate (mGluR1) antagonist | |||
| 0.102 | 0.023 | 0.102 | Amidase inhibitor | |||
| 0.104 | 0.025 | 0.104 | Vanilloid 1 antagonist | |||
| 0.084 | 0.006 | 0.084 | Potassium channel (ATP-sensitive) activator | |||
| 0.105 | 0.027 | 0.534 | Glutamate decarboxylase inhibitor | 0.534 0.002 CID_154699978 | CID_154699978 | |
| 0.102 | 0.026 | 0.102 | Caspase 7 inhibitor | |||
| 0.093 | 0.02 | 0.093 | Biliverdin reductase inhibitor | |||
| 0.15 | 0.078 | 0.556 | Peroxidase inhibitor | 0.556 0.006 CID_154699978 | CID_154699978 | |
| 0.144 | 0.075 | 0.261 | Thiol protease inhibitor | 0.261 0.024 CID_154699978 | CID_154699978 | |
| 0.086 | 0.017 | 0.086 | Thromboxane antagonist | |||
| 0.104 | 0.035 | 0.104 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.082 | 0.014 | 0.082 | Thromboxane A2 antagonist | |||
| 0.071 | 0.003 | 0.071 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.074 | 0.005 | 0.074 | Melatonin agonist | |||
| 0.169 | 0.101 | 0.169 | Pyruvate kinase inhibitor | |||
| 0.077 | 0.014 | 0.077 | Oleamide hydrolase inhibitor | |||
| 0.071 | 0.008 | 0.071 | Fumarate hydratase inhibitor | |||
| 0.17 | 0.107 | 0.17 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.143 | 0.082 | 0.143 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.084 | 0.024 | 0.084 | Dopamine uptake inhibitor | |||
| 0.089 | 0.029 | 0.089 | Glycine receptor agonist | |||
| 0.067 | 0.007 | 0.067 | Glutamate (mGluR3) antagonist | |||
| 0.07 | 0.009 | 0.07 | Purinergic P2X4 antagonist | |||
| 0.143 | 0.083 | 0.143 | GABA C receptor rho-2 antagonist | |||
| 0.102 | 0.042 | 0.102 | NADH dehydrogenase inhibitor | |||
| 0.084 | 0.024 | 0.084 | Potassium channel (ATP-sensitive) blocker | |||
| 0.093 | 0.033 | 0.093 | Estrogen receptor alpha antagonist | |||
| 0.064 | 0.005 | 0.064 | Heme oxygenase inhibitor | |||
| 0.265 | 0.208 | 0.265 | 5 Hydroxytryptamine release inhibitor | |||
| 0.059 | 0.002 | 0.059 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.081 | 0.024 | 0.081 | Alcohol oxidase inhibitor | |||
| 0.148 | 0.091 | 0.148 | Arachidonic acid antagonist | |||
| 0.064 | 0.01 | 0.064 | Benzodiazepine antagonist | |||
| 0.07 | 0.017 | 0.07 | Dihydroorotate oxidase inhibitor | |||
| 0.078 | 0.025 | 0.078 | Beta 3 adrenoreceptor antagonist | |||
| 0.123 | 0.071 | 0.123 | Glutamate receptor antagonist | |||
| 0.073 | 0.02 | 0.073 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.07 | 0.018 | 0.07 | CC chemokine 5 receptor antagonist | |||
| 0.06 | 0.01 | 0.077 | Membrane dipeptidase inhibitor | 0.077 0.005 CID_154699978 | CID_154699978 | |
| 0.138 | 0.088 | 0.138 | MAP kinase 3 inhibitor | |||
| 0.132 | 0.082 | 0.172 | Lipid peroxidase inhibitor | 0.172 0.054 CID_154699978 | CID_154699978 | |
| 0.075 | 0.027 | 0.075 | CDK4/cyclin D1 inhibitor | |||
| 0.067 | 0.02 | 0.067 | Aconitate hydratase inhibitor | |||
| 0.072 | 0.026 | 0.072 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.055 | 0.01 | 0.055 | Kainate receptor agonist | |||
| 0.084 | 0.039 | 0.182 | Aminopeptidase I inhibitor | 0.182 0.008 CID_154699978 | CID_154699978 | |
| 0.055 | 0.01 | 0.055 | AMPA 2 receptor antagonist | 0.044 0.013 CID_154699978 | ||
| 0.053 | 0.008 | 0.053 | AMPA 3 receptor antagonist | 0.046 0.011 CID_154699978 | ||
| 0.062 | 0.019 | 0.062 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.072 | 0.03 | 0.093 | Carbonic anhydrase stimulant | 0.093 0.021 CID_154699978 | CID_154699978 | |
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR4) antagonist | |||
| 0.052 | 0.012 | 0.052 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.063 | 0.024 | 0.063 | AMPA receptor antagonist | |||
| 0.065 | 0.026 | 0.065 | Sphingosine kinase 2 inhibitor | |||
| 0.064 | 0.026 | 0.064 | 5 Hydroxytryptamine 7 agonist | |||
| 0.081 | 0.042 | 0.081 | Adenosine A3 receptor antagonist | |||
| 0.237 | 0.2 | 0.237 | DNA directed DNA polymerase inhibitor | |||
| 0.053 | 0.017 | 0.053 | Glutamate (mGluR group III) antagonist | |||
| 0.068 | 0.032 | 0.068 | Phosphodiesterase 1C inhibitor | |||
| 0.077 | 0.043 | 0.077 | Phosphofructokinase-1 inhibitor | |||
| 0.1 | 0.065 | 0.362 | Aminopeptidase B inhibitor | 0.362 0.005 CID_154699978 | CID_154699978 | |
| 0.042 | 0.008 | 0.042 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.109 | 0.075 | 0.109 | Anesthetic local | |||
| 0.174 | 0.143 | 0.224 | Calpain inhibitor | 0.224 0.09 CID_154699978 | CID_154699978 | |
| 0.067 | 0.036 | 0.067 | NMDA 2C receptor antagonist | |||
| 0.035 | 0.005 | 0.035 | Complement factor 1s inhibitor | |||
| 0.085 | 0.055 | 0.114 | Inducible nitric-oxide synthase inhibitor | 0.114 0.027 CID_154699978 | CID_154699978 | |
| 0.032 | 0.004 | 0.032 | Thyroid hormone alpha agonist | |||
| 0.053 | 0.025 | 0.053 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.102 | 0.074 | 0.102 | Protein kinase (CK2) alpha inhibitor | |||
| 0.04 | 0.012 | 0.04 | Uridine phosphorylase inhibitor | |||
| 0.03 | 0.005 | 0.03 | Thyroid hormone alpha antagonist | |||
| 0.106 | 0.08 | 0.106 | Microtubule formation inhibitor | |||
| 0.053 | 0.027 | 0.053 | Kallikrein inhibitor | |||
| 0.038 | 0.013 | 0.038 | Sigma 2 receptor antagonist | |||
| 0.053 | 0.028 | 0.053 | Squalene epoxidase inhibitor | |||
| 0.046 | 0.021 | 0.046 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.095 | 0.07 | 0.095 | GABA C receptor rho-1 antagonist | |||
| 0.068 | 0.044 | 0.068 | Glutamate (mGluR6) antagonist | |||
| 0.035 | 0.011 | 0.035 | 5 Hydroxytryptamine 6 agonist | |||
| 0.077 | 0.053 | 0.077 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.085 | 0.061 | 0.085 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.101 | 0.077 | 0.101 | GABA C receptor antagonist | |||
| 0.033 | 0.01 | 0.033 | Nicotinic acid receptor 2 antagonist | |||
| 0.032 | 0.01 | 0.032 | Thymidine phosphorylase inhibitor | |||
| 0.047 | 0.026 | 0.047 | AICAR transformylase inhibitor | |||
| 0.045 | 0.023 | 0.045 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.034 | 0.012 | 0.034 | MAP3K8 inhibitor | |||
| 0.118 | 0.097 | 0.118 | CDC-like kinase 1 inhibitor | |||
| 0.083 | 0.062 | 0.083 | NMDA receptor antagonist | |||
| 0.063 | 0.042 | 0.063 | NMDA receptor glycine site agonist | |||
| 0.049 | 0.029 | 0.077 | Thymidylate synthase inhibitor | 0.077 0.008 CID_154699978 | CID_154699978 | |
| 0.063 | 0.042 | 0.063 | Adrenaline uptake inhibitor | |||
| 0.064 | 0.044 | 0.064 | Interferon inducer | |||
| 0.086 | 0.066 | 0.086 | Potassium channel activator | |||
| 0.051 | 0.033 | 0.051 | Potassium channel (Inward rectifier) blocker | |||
| 0.076 | 0.059 | 0.076 | Interferon agonist | |||
| 0.019 | 0.002 | 0.019 | DNA topoisomerase III inhibitor | |||
| 0.06 | 0.043 | 0.06 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.056 | 0.039 | 0.056 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.077 | 0.061 | 0.077 | Carbonic anhydrase VI inhibitor | |||
| 0.044 | 0.028 | 0.044 | Dihydrofolate reductase inhibitor | |||
| 0.089 | 0.073 | 0.089 | Protein kinase (CK2) inhibitor | |||
| 0.052 | 0.036 | 0.052 | NMDA 2A receptor antagonist | |||
| 0.08 | 0.066 | 0.08 | Estrogen-related receptor beta agonist | |||
| 0.055 | 0.041 | 0.055 | Beta 1 adrenoreceptor antagonist | |||
| 0.035 | 0.022 | 0.035 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.057 | 0.043 | 0.057 | CDK4/cyclin D inhibitor | |||
| 0.057 | 0.045 | 0.057 | Heat shock protein 90 beta antagonist | |||
| 0.07 | 0.059 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.016 | 0.005 | 0.016 | Carbonic anhydrase XI inhibitor | |||
| 0.049 | 0.038 | 0.049 | Beta 2 adrenoreceptor antagonist | |||
| 0.09 | 0.078 | 0.136 | Nitric-oxide synthase inhibitor | 0.136 0.029 CID_154699978 | CID_154699978 | |
| 0.079 | 0.068 | 0.079 | Myeloperoxidase inhibitor | |||
| 0.062 | 0.051 | 0.062 | Beta adrenoreceptor antagonist | |||
| 0.051 | 0.041 | 0.051 | Alpha-mannosidase inhibitor | |||
| 0.055 | 0.045 | 0.055 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.019 | 0.009 | 0.019 | CXC chemokine 5 receptor antagonist | |||
| 0.035 | 0.025 | 0.035 | Phosphoglycerate kinase inhibitor | |||
| 0.03 | 0.02 | 0.052 | AMPA 1 receptor antagonist | 0.052 0.011 CID_154699978 | CID_154699978 | |
| 0.017 | 0.007 | 0.017 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.018 | 0.008 | 0.018 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.013 0.011 CID_154699978 | ||
| 0.038 | 0.03 | 0.038 | Dopamine D5 agonist | |||
| 0.027 | 0.02 | 0.027 | Glucosylceramidase stimulant | |||
| 0.053 | 0.046 | 0.053 | Adenosine A1 receptor antagonist | |||
| 0.018 | 0.011 | 0.018 | Alpha 2a adrenoreceptor agonist | |||
| 0.083 | 0.077 | 0.083 | Platelet activating factor alpha antagonist | |||
| 0.077 | 0.071 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.047 | 0.041 | 0.047 | Aldose reductase inhibitor | |||
| 0.042 | 0.036 | 0.042 | Histamine H1 receptor agonist | |||
| 0.025 | 0.02 | 0.025 | Acid ceramidase inhibitor | |||
| 0.064 | 0.059 | 0.064 | Exportin-1 inhibitor | |||
| 0.057 | 0.054 | 0.057 | 5 Hydroxytryptamine 3 agonist | |||
| 0.045 | 0.043 | 0.045 | Dopamine beta hydroxylase inhibitor | |||
| 0.016 | 0.014 | 0.016 | Adenosine A3 receptor agonist | |||
| 0.192 | 0.19 | 0.192 | Vasodilator, coronary | |||
| 0.019 | 0.017 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.029 | 0.028 | 0.029 | ATP citrate lysase inhibitor | |||
| 0.018 | 0.017 | 0.018 | Kainate receptor 5 antagonist | |||
| 0.038 | 0.037 | 0.038 | Guanylate cyclase inhibitor | |||
| 0.058 | 0.06 | 0.069 | Phenylalanine 4-hydroxylase inhibitor | 0.069 0.047 CID_154699978 | CID_154699978 | |
| 0.036 | 0.04 | 0.042 | Leukocyte elastase inhibitor | 0.042 0.031 CID_154699978 | CID_154699978 | |
| 0.041 | 0.05 | 0.117 | Ornithine carbamoyltransferase inhibitor | 0.117 0.013 CID_154699978 | CID_154699978 | |
| 0.071 | 0.08 | 0.401 | Glutathione S-transferase inhibitor | 0.401 0.002 CID_154699978 | CID_154699978 | |
| 0.108 | 0.119 | 0.119 | Vanilloid 1 agonist | 0.119 0.09 CID_154699978 | CID_154699978 | |
| 0.063 | 0.077 | 0.084 | Somatostatin 1 agonist | 0.084 0.047 CID_154699978 | CID_154699978 | |
| 0.051 | 0.065 | 0.095 | NMDA receptor agonist | 0.095 0.021 CID_154699978 | CID_154699978 | |
| 0.053 | 0.069 | 0.084 | Protease 3C (Human rhinovirus) inhibitor | 0.084 0.024 CID_154699978 | CID_154699978 | |
| 0.042 | 0.061 | 0.061 | Carbonic anhydrase II stimulant | 0.061 0.022 CID_154699978 | CID_154699978 | |
| 0.175 | 0.196 | 0.185 | Transcription factor NF kappa B inhibitor | 0.185 0.184 CID_154699978 | CID_154699978 | |
| 0.017 | 0.04 | 0.051 | Lysine carboxypeptidase inhibitor | 0.051 0.007 CID_154699978 | CID_154699978 | |
| 0.08 | 0.114 | 0.157 | Mucolytic | 0.157 0.028 CID_154699978 | CID_154699978 | |
| 0.033 | 0.075 | 0.072 | Lysophosphatidic acid 3 receptor antagonist | 0.072 0.013 CID_154699978 | CID_154699978 | |
| 0.007 | 0.049 | 0.027 | Aminopeptidase A inhibitor | 0.027 0.007 CID_154699978 | CID_154699978 | |
| 0.03 | 0.078 | 0.037 | Integrin alpha1beta1 antagonist | 0.037 0.03 CID_154699978 | CID_154699978 | |
| 0.023 | 0.076 | 0.04 | Growth hormone release inhibitor | 0.04 0.031 CID_154699978 | CID_154699978 | |
| 0.043 | 0.096 | 0.141 | Catalase inhibitor | 0.141 0.028 CID_154699978 | CID_154699978 | |
| 0.092 | 0.162 | 0.388 | Phospholipase A2 inhibitor | 0.388 0.005 CID_154699978 | CID_154699978 | |
| 0.06 | 0.135 | 0.135 | Expectorant | 0.135 0.042 CID_154699978 | CID_154699978 | |
| 0.019 | 0.101 | 0.124 | Ribonucleoside-diphosphate reductase inhibitor | 0.124 0.015 CID_154699978 | CID_154699978 | |
| 0.004 | 0.089 | 0.02 | Ileal bile acid transport inhibitor | 0.02 0.009 CID_154699978 | CID_154699978 | |
| 0.018 | 0.103 | 0.119 | Ribonucleotide reductase inhibitor | 0.119 0.017 CID_154699978 | CID_154699978 | |
| 0.018 | 0.109 | 0.081 | Antimetabolite | 0.081 0.019 CID_154699978 | CID_154699978 | |
| 0.033 | 0.128 | 0.057 | CD45 antagonist | 0.057 0.025 CID_154699978 | CID_154699978 | |
| 0.042 | 0.144 | 0.088 | Ornithine decarboxylase inhibitor | 0.088 0.058 CID_154699978 | CID_154699978 | |
| 0.006 | 0.115 | 0.043 | Arginase inhibitor | 0.043 0.019 CID_154699978 | CID_154699978 | |
| 0.11 | 0.221 | 0.335 | Phospholipase C inhibitor | 0.335 0.015 CID_154699978 | CID_154699978 | |
| 0.146 | 0.262 | 0.34 | Insulysin inhibitor | 0.34 0.038 CID_154699978 | CID_154699978 | |
| 0.015 | 0.134 | 0.15 | Toll-Like receptor 2 agonist | 0.15 0.011 CID_154699978 | CID_154699978 | |
| 0.029 | 0.15 | 0.071 | Bombesin 2 receptor antagonist | 0.071 0.019 CID_154699978 | CID_154699978 | |
| 0.04 | 0.161 | 0.084 | Metalloproteinase-9 inhibitor | 0.084 0.041 CID_154699978 | CID_154699978 | |
| 0.098 | 0.223 | 0.418 | Immunostimulant | 0.418 0.045 CID_154699978 | CID_154699978 | |
| 0.066 | 0.196 | 0.178 | Toll-Like receptor 2 antagonist | 0.178 0.035 CID_154699978 | CID_154699978 | |
| 0.056 | 0.188 | 0.109 | Proteasome inhibitor | 0.109 0.076 CID_154699978 | CID_154699978 | |
| 0.016 | 0.165 | 0.091 | Neutrophil collagenase inhibitor | 0.091 0.026 CID_154699978 | CID_154699978 | |
| 0.011 | 0.183 | 0.055 | Matrix metalloproteinase 1 inhibitor | 0.055 0.035 CID_154699978 | CID_154699978 | |
| 0.05 | 0.233 | 0.173 | Bone formation stimulant | 0.173 0.044 CID_154699978 | CID_154699978 | |
| 0.101 | 0.285 | 0.163 | Neurotensin receptor agonist | 0.163 0.073 CID_154699978 | CID_154699978 | |
| 0.013 | 0.199 | 0.044 | Endothelin-converting enzyme inhibitor | 0.044 0.034 CID_154699978 | CID_154699978 | |
| 0.02 | 0.214 | 0.078 | Matrix metalloproteinase inhibitor | 0.078 0.038 CID_154699978 | CID_154699978 | |
| 0.028 | 0.222 | 0.112 | Metalloproteinase-2 inhibitor | 0.112 0.033 CID_154699978 | CID_154699978 | |
| 0.128 | 0.339 | 0.28 | Histamine release inhibitor | 0.28 0.135 CID_154699978 | CID_154699978 | |
| 0.069 | 0.28 | 0.165 | Interleukin agonist | 0.165 0.154 CID_154699978 | CID_154699978 | |
| 0.01 | 0.225 | 0.048 | HIV-1 protease inhibitor | 0.048 0.024 CID_154699978 | CID_154699978 | |
| 0.01 | 0.243 | 0.044 | Metalloproteinase-3 inhibitor | 0.044 0.04 CID_154699978 | CID_154699978 | |
| 0.012 | 0.251 | 0.048 | Aminopeptidase N inhibitor | 0.048 0.033 CID_154699978 | CID_154699978 | |
| 0.057 | 0.303 | 0.219 | Insulin sensitizer | 0.219 0.056 CID_154699978 | CID_154699978 | |
| 0.018 | 0.281 | 0.068 | Aminopeptidase microsomal inhibitor | 0.068 0.033 CID_154699978 | CID_154699978 | |
| 0.09 | 0.355 | 0.224 | Gastrin inhibitor | 0.224 0.114 CID_154699978 | CID_154699978 | |
| 0.092 | 0.364 | 0.212 | Antithrombotic | 0.212 0.163 CID_154699978 | CID_154699978 | |
| 0.009 | 0.283 | 0.065 | Glycine transporter 2 inhibitor | 0.065 0.023 CID_154699978 | CID_154699978 | |
| 0.03 | 0.305 | 0.059 | Trypsin inhibitor | 0.059 0.049 CID_154699978 | CID_154699978 | |
| 0.029 | 0.345 | 0.156 | Histone deacetylase class III inhibitor | 0.156 0.039 CID_154699978 | CID_154699978 | |
| 0.018 | 0.359 | 0.088 | Sirtuin 1 inhibitor | 0.088 0.029 CID_154699978 | CID_154699978 | |
| 0.017 | 0.381 | 0.055 | Cathepsin B inhibitor | 0.055 0.041 CID_154699978 | CID_154699978 | |
| 0.006 | 0.37 | 0.048 | Collagenase inhibitor | 0.048 0.036 CID_154699978 | CID_154699978 | |
| 0.015 | 0.38 | 0.054 | Human rhinovirus A protease inhibitor | 0.054 0.039 CID_154699978 | CID_154699978 | |
| 0.023 | 0.462 | 0.093 | Bcl-xL inhibitor | 0.093 0.007 CID_154699978 | CID_154699978 | |
| 0.004 | 0.454 | 0.067 | Leukotriene A4 hydrolase inhibitor | 0.067 0.013 CID_154699978 | CID_154699978 | |
| 0.02 | 0.565 | 0.37 | Angiogenesis stimulant | 0.37 0.027 CID_154699978 | CID_154699978 | |
| 0.012 | 0.598 | 0.129 | Protease inhibitor | 0.129 0.041 CID_154699978 | CID_154699978 | |
| 0.005 | 0.608 | 0.088 | Selectin antagonist | 0.088 0.033 CID_154699978 | CID_154699978 | |
| 0.006 | 0.623 | 0.051 | Carbonic anhydrase I stimulant | 0.051 0.015 CID_154699978 | CID_154699978 | |
| 0.01 | 0.687 | 0.271 | Anticoagulant | 0.271 0.034 CID_154699978 | CID_154699978 | |
| 0.011 | 0.693 | 0.044 | Glutamate (mGluR8) antagonist | 0.044 0.012 CID_154699978 | CID_154699978 | |
| 0.017 | 0.71 | 0.072 | Adenine nucleotide translocase inhibitor | 0.072 0.013 CID_154699978 | CID_154699978 | |
| 0.001 | 0.72 | 0.023 | Aminopeptidase P inhibitor | 0.023 0.016 CID_154699978 | CID_154699978 | |
| 0.004 | 0.79 | 0.073 | Angiotensin-converting enzyme inhibitor | 0.073 0.018 CID_154699978 | CID_154699978 | |
| 0.013 | 0.836 | 0.054 | DNA helicase inhibitor | 0.054 0.039 CID_154699978 | CID_154699978 | |
| 0.007 | 0.834 | 0.044 | Neurokinin 2 agonist | 0.044 0.025 CID_154699978 | CID_154699978 | |
| 0.006 | 0.845 | 0.126 | Chelator | 0.126 0.048 CID_154699978 | CID_154699978 | |
| 0.004 | 0.85 | 0.063 | Bcl2 antagonist | 0.063 0.051 CID_154699978 | CID_154699978 | |
| 0.011 | 0.896 | 0.115 | Nav1.4 sodium channel blocker | 0.115 0.057 CID_154699978 | CID_154699978 | |
| 0.007 | 0.906 | 0.099 | Factor XII inhibitor | 0.099 0.038 CID_154699978 | CID_154699978 | |
| 0.005 | 0.904 | 0.049 | Neurotensin receptor antagonist | 0.049 0.029 CID_154699978 | CID_154699978 | |
| 0.014 | 0.915 | 0.223 | Hepatoprotectant | 0.223 0.053 CID_154699978 | CID_154699978 | |
| 0.005 | 0.915 | 0.366 | Platelet antagonist | 0.366 0.034 CID_154699978 | CID_154699978 | |
| 0.021 | 0.948 | 0.146 | Factor V inhibitor | 0.146 0.02 CID_154699978 | CID_154699978 | |
| 0.006 | 0.949 | 0.06 | Bombesin 1 receptor agonist | 0.06 0.04 CID_154699978 | CID_154699978 | |
| 0.004 | 0.952 | 0.059 | Erythropoietin receptor agonist | 0.059 0.018 CID_154699978 | CID_154699978 | |
| 0.002 | 0.955 | 0.059 | Complement C3a chemotactic receptor antagonist | 0.059 0.022 CID_154699978 | CID_154699978 | |
| 0.002 | 0.959 | 0.034 | Protocollagen prolyl hydroxylase inhibitor | 0.034 0.011 CID_154699978 | CID_154699978 | |
| 0.005 | 0.962 | 0.048 | Cathepsin F inhibitor | 0.048 0.016 CID_154699978 | CID_154699978 | |
| 0.029 | 0.994 | 0.285 | Peptidyltransferase inhibitor | 0.285 0.031 CID_154699978 | CID_154699978 | |
| 0.016 | 0.983 | 0.304 | Growth hormone agonist | 0.304 0.032 CID_154699978 | CID_154699978 | |
| 0.019 | 0.993 | 0.335 | Interleukin 2 agonist | 0.335 0.052 CID_154699978 | CID_154699978 | |
| 0.013 | 0.988 | 0.136 | Folate antagonist | 0.136 0.028 CID_154699978 | CID_154699978 | |
| 0.011 | 0.988 | 0.092 | Transcription factor NF kappa B stimulant | 0.092 0.048 CID_154699978 | CID_154699978 | |
| 0.002 | 0.983 | 0.064 | GP IIb/IIIa receptor antagonist | 0.064 0.026 CID_154699978 | CID_154699978 | |
| 0.004 | 0.986 | 0.042 | Cholecystokinin B agonist | 0.042 0.022 CID_154699978 | CID_154699978 | |
| 0.005 | 0.989 | 0.281 | Apoptosis antagonist | 0.281 0.099 CID_154699978 | CID_154699978 | |
| 0.006 | 0.992 | 0.057 | Caspase 9 inhibitor | 0.057 0.055 CID_154699978 | CID_154699978 | |
| 0.004 | 0.991 | 0.399 | Interleukin antagonist | 0.399 0.031 CID_154699978 | CID_154699978 | |
| 0.001 | 0.992 | 0.03 | Bradykinin B2 receptor agonist | 0.03 0.018 CID_154699978 | CID_154699978 | |
| 0.004 | 0.996 | 0.147 | Hematopoietic | 0.147 0.015 CID_154699978 | CID_154699978 | |
| 0.004 | 0.995 | 0.19 | Histone deacetylase SIRT1 inhibitor | 0.19 0.034 CID_154699978 | CID_154699978 | |
| 0.003 | 0.995 | 0.316 | Thrombolytic | 0.316 0.021 CID_154699978 | CID_154699978 | |
| 0.002 | 0.995 | 0.045 | Bombesin antagonist | 0.045 0.039 CID_154699978 | CID_154699978 | |
| 0.002 | 0.996 | 0.078 | Nitric oxide donor | 0.078 0.024 CID_154699978 | CID_154699978 | |
| 0.002 | 0.996 | 0.043 | Integrin alpha5beta1 antagonist | 0.043 0.024 CID_154699978 | CID_154699978 | |
| 0.002 | 0.996 | 0.094 | Glucagon-like peptide 1 agonist | 0.094 0.025 CID_154699978 | CID_154699978 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |